Sign in

NCT06375460Recruiting

Real-time Engagement for Learning to Effectively Control Type 2 Diabetes

Source: ClinicalTrials.gov · Last updated 7 Oct 2026

Brief summary (registry, in English)

The goal of this clinical trial is to learn if a new smartphone app that pairs glucose and exercise data will help adolescents and young adults with type 2 diabetes improve glycemic control. It will also study how changes in glycemic control are maintained over time. The main questions it aims to answer are: * Does using the app help with short-term glycemic control? * Does using the app help with longer-term glycemic control? * Does using the app help increase physical activity? Participants will: * Wear a continuous glucose monitoring device for 6 months * Wear a physical activity tracker for 6 months * Use the study smartphone app for 6 months * Complete 3 in-person study visits with fasting blood draws * Report dietary intake intermittently throughout the study

Status (registry)
Recruiting
Study type
Interventional
Enrollment
100 (estimated)
First submitted
14 Mar 2024
Start date
20 Sept 2026
Primary completion date
31 Jul 2029
Lead sponsor
University of Pittsburgh
NCT number
NCT06375460

What you commit to

  • Study type: Interventional
  • Planned participants: 100
  • From 20 Sept 2026 to the primary completion date, 31 Jul 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Current or previously diagnosed eating disorder

Other illness

  • Cognitive impairment or severe psychiatric condition that could interfere with participation in behavioral intervention for diabetes self-management

Other

  • Current pregnancy
  • Hydroxyurea use (CGM sensor inaccuracies)

Who the study is looking for

  • type 2 diabetes: negative diabetes autoantibodies, no suspicion for monogenic diabetes
  • English-speaking (app in English)

Age in the registry: 14 years to 26 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
UPMC Children's Hospital of Pittsburgh
Coordinator of this site? Confirm its status
PittsburghUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.